Assessment of IL- 35 Gene Polymorphism in Periodontitis Patients with and without Diabetes - A Cross-Sectional Study Authors: J Sri Vishnu Durga, R Renuka Devi, S Sonika, T Vignesh Published: 2024 ABSTRACT ABSTRACTAim:To evaluate the IL-35 Gene Polymorphism in Periodontitis subjects with and without type 2 diabetes mellitus.Methodology:96 participants were categorized into three groups, Group 1: Systemically and Periodontally healthy individuals, Group 2: Systemically healthy patients with Generalized chronic periodontitis, Group 3: Generalized chronic periodontitis with type 2 diabetes Mellitus. Genomic DNA was extracted from the whole venous blood samples collected from the participants using The PureLink Genomic Kit. The region spanning rs1580809257 and rs1580801731 were amplified using appropriate primer and reaction conditions. Determination of genotypes for each of the polymorphisms assessed using Amplification Refractory Mutation System (ARMS) - based PCR and Restriction Fragment Length Polymorphism (RFLP). The distribution of genotype and allele frequencies for Case and control groups were compared using the Chi-square test. Hardy Weinberg equilibrium is calculated.Results:The gene and allele frequency were found to be similar in all three groups.Conclusion:The study reveals that polymorphism of rs1580809257 and rs1580801731 in the IL-35 gene is neither associated with Periodontitis patients nor Periodontitis with Diabetes patients. INTRODUCTION Inflammatory diseases present a complex paradox: while acting as vital immune responses within the body, they also inflict damage upon the host. Periodontal disease depicts this phenomenon, with bacterial plaque serving as its etiological factor, while the host response manifests as destructive inflammation targeting host tissue. This inflammatory process is directed by a multitude of inflammatory mediators, chiefly cytokines, whose roles serve as pivotal determinants in disease progression. Periodontitis is significantly associated with genetic factors, wherein the production of inflammatory mediators is directly influenced by genetic predispositions.[1] Genetic polymorphisms, which are multiple forms of a gene within a population, can influence an individual’s susceptibility to certain diseases, including periodontal disease. One well-identified genetic polymorphism related to periodontal disease is the gene encoding for interleukin-1 (IL-1), a Pro-inflammatory cytokine involved in the immune response. Polymorphisms in the IL-1 gene are linked with more risk of periodontal disease progression and greater severity of the condition. Polymorphisms in the interleukin genes may predominantly affect the expression level of interleukin molecules. It causes changes in an amino acid arrangement that results in the secretion of unregulated or dysfunctional protein. This altered protein expression is certainly associated with the severity of periodontal disease.[2] Understanding the role of genetic polymorphisms in periodontal disease susceptibility can aid in identifying individuals at higher risk for the condition and developing personalized treatment approaches tailored to their genetic profile. Additionally, there is growing interested in exploring potential correlations between IL-35 polymorphisms and diabetes-related influence on periodontal disease, offering insights into tailored approaches for managing these conditions.[3] MATERIALS AND METHODS A total of 96 individuals were chosen from the subjects reporting to the Department of Periodontology. The study design was authorized by the institutional ethical committee board. The study participants gave their consent to be involved after a proper explanation of the study protocol. This cross-sectional study was done with 96 subjects who were equally divided into three different groups Group 1: Systemically and Periodontally healthy individuals, Group 2: Systemically healthy patients with generalized chronic periodontitis, and Group 3: Generalized chronic periodontitis with type 2 Diabetes Mellitus. Clinical parameters such as plaque index, gingival index, probing pocket depth and clinical attachment level were measured using a mouth mirror, dental explorer, and William’s graduated periodontal probe. Sample collection and DNA extraction A total of 5 ml of peripheral venous blood sample from the median cubital vein was collected under aseptic conditions from the antecubital in an EDTA vacutainer and stored at 4°Cc in a fridge. DNA isolation was done under PureLink™ Genomic DNA Mini Kit. Polymerase chain reaction and restriction endonuclease digestion For genotyping analysis PCR (Polymerase Chain Reaction) and RFLP (Restriction fragmentation length Polymorphism) method was used. The NAT2 primers IL35 -F -GAAGTGAGTTTGGACTTACGA IL35 R- TTAGGGAACTTAGCAGAGAGC were used to amplify the DNA. The PCR was performed in 20 ul containing 50ng of genomic DNA, 5 pmol/ul of each primer, and PCR master mix [Takara, Shiga, Japan]. PCR is carried out in a thermal cycler with a condition that includes an initial denaturation at 95°C for 5 min followed by 39 cycles of denaturation at 95°C for 35 seconds, primer annealing at 64°C for 35 seconds, extension at 72°C for 35 seconds and a final extension at 72°C for 5 min. The Amplicon size of PCR was 547bp. The amplified PCR product was checked on a 1% agarose gel electrophoresis. RFLP (Restriction fragmentation length polymorphism) The PCR product was digested with TaqI restriction enzyme [New England Biolabs, UK] at 65°C. The digested product was electrophoresed in 2% agarose with 0.5 μg/ml ethidium bromide and photographed using a gel documentation system. ARMS PCR (Amplification refractory mutation system) For genotyping analysis ARMS PCR) the NAT2 primers IL 35 F1- CATCTGATTTGCCAACAAGATT IL35F2-CATCTGATTTGCCAACAAGATA IL35R- GGATTATGAAGTGACTCTCAC were used to amplify the DNA. The PCR was done in 20 ul containing 50ng of genomic DNA, 5 pmol/ul of each primer, and PCR master mix [Takara, Shiga, Japan]. PCR is performed in a thermal cycler of an initial denaturation at 95°C for 5 min followed by 39 cycles of denaturation at 95°centigrade for 35 seconds, primer annealing at 64°Centigrade for 35 seconds, extension at 72°Centigrade for 35 seconds and a final extension at 72°Centigrade for 5 min. The Amplicon size of PCR was 547bp. 1% agarose gel electrophoresis was used to examine the amplified PCR product. Statistical analysis Statistical analysis was performed using SPSS version 22.0, Statistical software. The significance level was set to P < 0.05 statistics. The distribution of Genotype of IL-35 Gene polymorphism between the three groups was examined using post hoc. The level of significance was set at P < 0.05. The risk associated with individuals between three groups is calculated using Hardy Weinberg Equilibrium. RESULTS Graph 1a and 1b: (a) Genotype frequencies among three groups. (b) Allele frequencies among three groups Overall genotype distribution of the gene polymorphism rs1580809257 among three different groups shows the Predominant genotype observed among all Groups (Group 1, Group 2, Group 3) is the ‘TA’ heterozygous variant allele followed by TT and AA with TT (ancestral allele) more predominant in healthy patients alone. The frequency of the A allele is more in three groups than the T allele. A Deflection from Hardy-Weinberg Equilibrium Was Observed in All Study Groups (P value < 0.05), implying the fact that the genetic variation observed in this population will not remain the same for successive generations. This observation can be attributed to parameters such as small sample size, nonrandom mating, natural selection and mutations. The genotype and allele frequencies among the study groups showed similar results. The Chi-Square test at one degree of freedom revealed that there is no difference significantly upon comparison of the two groups viz., PD + DM vs PD, P value = 0.7625; PD + DM vs Control, P value = 0.7836. Graph 2a and 2b: (a) Genotype frequencies among three groups. (b) Allele frequencies among three groups Overall distribution of genotype of the gene polymorphism rs150801731 within the different groups shows that all are Monomorphic (GG) ancestral alleles only present. A Deviation from Hardy Weinberg Equilibrium Was Observed in All The Study Groups (P value < 0.05). In this study subjects in Group 1 have a mean age of 36.5 with a range of 28–51 years and subjects in Group 2 have a mean age of 46. 7 with a range of 27–74 years and Group 3 has a mean age of 57.6 with a range of 47–75 years. The difference in the age between the three groups is not statistically significant at P < 0.001. And in Gender Group 1 has males and females 50%, Group 2 have males 38%, females 63%, and Group 3 has males 65%, females 35%. In the evaluation of clinical parameters between the 3 group. All three groups show difference that is statistically significant (P < 0.01) among the clinical parameters of Plaque index (PI), Probing pocket depth (PPD) and clinical attachment level which was analysed through the Duncan mean test. There is a significant difference among all the clinical parameters (PI, PPD, and CAL), between the groups (group 1, group 2, group 3), but the clinical parameters do not show any significant variation within every individual group at P < 0.01. Significant difference at P < 0.001 among clinical parameters. Further, the Clinical Attachment Level (CAL) parameter is high among all the groups and showed differences, which are statistically significant at P < 0.001. Figures 1 and 2: Further, insilico analysis are done and we utilized the Imutant 2.0 In silico analysis tool to predict protein stability. substituting the amino acid asparagine to tyrosine in the rs1580809257 gene decreased the stability of the encoded protein, resulting in a free energy change of − 0.09 as shown in Figures 1 and 2. Additionally, replacing proline with leucine in rs150801731 also decreased protein stability, with a free energy change (DDG value) of 0.61, as shown in Figures 1 and 2. (a and b) Insilico analysis utilized the Imutant 2.0 tool to predict protein stability for rs1580809257 (a and b) Insilico analysis utilized the Imutant 2.0 tool to predict protein stability for rs150801731 Figure 3: We used the polyphen In silico analysis tool to predict protein stability and showed that the amino acid sequence of rs1580809257 and rs150801731 would probably be damaging the protein function with a score of 1.00 as shown in Figure 3. Polyphen In silico analysis tool to predict protein stability Figure 4: And we used the SIFT Insilico analysis tool to predict protein stability and showed that the amino acid sequence of rs1580809257 and rs150801731 would affect the protein function with 0.00, as seen in Figure 4. SIFT In silico analysis tool to predict protein stability DISCUSSION Periodontal disease is an inflammatory condition influenced by the host’s inflammatory response, with cytokines like interleukins playing a crucial role in triggering inflammation. These cytokines, such as interleukins, have dual roles as pro-inflammatory and anti-inflammatory mediators, contributing to the destruction of periodontal structures.[4] Maintaining a balance between these cytokines is crucial for preserving periodontal health and gene factors regulating cytokine production play a significant role in regulating this balance. IL-35 is a newly identified interleukin which belong to IL-12 family, play multifaceted role in regulating immune balance and reported to have protective effects in diabetes and periodontal diseases. Understanding the balance between these roles is essential for its therapeutic potential and disease management.[5] The studies conducted by Kosiglu et al. (2015),[6] and Ashwini Jadhav et al. (2022)[7] revealed that IL-35 concentrations were higher in healthy gingival tissues compared to those with gingivitis and periodontitis, indicating an anti-inflammatory effect. Conversely, Ammu Varghese et al. (2020)[8] and P. Yuvashri et al. (2024)[9] observed increased IL-35 levels in periodontitis patients, suggesting a potential association with inflammation and a possible pro-inflammatory function.[10] Since evidence is scarce regarding the role of IL-35 as either a pro-inflammatory or anti-inflammatory cytokine, we decided to investigate potential polymorphisms within the IL-35 gene. The study focuses on the genetic polymorphism of Interleukin-35 (IL-35) and its potential implications in periodontal disease pathogenesis. The researchers examined IL-35 gene polymorphism in 96 patients from the outpatient department of periodontology, dividing them into periodontally healthy patients, a systemically healthy periodontitis group, and periodontitis with type 2 diabetes group. They used Pure Link Genomic Kit for DNA isolation and explored complex genetic details and identified IL-35 missense variants of interest using genomic tools Ensembl and Imutant, Polyphen, and SIFT.[11] The study found that the IL-6ST gene and its missense variants rs1580809257 and rs1580801731 were pathogenic due to their low energy levels. The Sift insilico tool was used to distinguish between intolerant and tolerant variants, with a score of 0.00 for both variants. Polyphen predicted a score of 1.000 for both variants, which was likely damaging. Statistically significant differences were observed between the groups, with the mutant variant TA exhibiting higher expression in the control group than the periodontitis group. The homozygous mutant variant AA showed higher expression in the periodontitis group, followed by the periodontitis with diabetes group, and the control group. The allele expression of T was common in both the control and periodontitis groups. In contrast, the allele expression of A was similar across the control, periodontitis, and periodontitis with diabetes groups.[12] The study found that the genetic variation in the population does not align with the Hardy-Weinberg principle, which suggests stable allele frequencies without evolutionary influences. This highlights that few evolutionary factors may reflect on the population, which leads to variations in allele frequencies in a due course of time. The Interleukin-35 gene polymorphism for rs15080809257 suggests that the observed genetic variation may not be stably transmitted to future generations due to evolutionary processes. Although the absence of a relationship between rs1580809257 and rs1580801731 gene polymorphism and periodontal disease is not definitive, it is crucial to continue research into pathogenic variants using extensive population databases. Advanced technology is used to improve future disease prediction using New Generation Sequencing Methods can also employed to find genetic variation. The integration of genetic polymorphism analysis into periodontal care enables personalized treatment strategies, leading to improved patient outcomes and more effective disease management. Limitations Our study’s limitations include the minimal sample size and potential confounding variables. This is the first study in the scientific literature to figure out the polymorphism in the gene encoding IL-35. Thus, the results of our study could not be compared with any other studies. Our study would pave the way for many future studies in the future to determine the possible association between periodontitis and IL -35 gene. CONCLUSION Thus, our study concludes that rs1580809257 and rs150801731 polymorphisms are not related to periodontitis and/or periodontitis associated with type 2 diabetes mellitus. Conflicts of interest There are no conflicts of interest.